Predict your next investment

Corporation
HEALTHCARE | Biotechnology
kangcell.com

See what CB Insights has to offer

Investments

1

About Kangcell Biotechnology

Kangcell Biotechnology is engaged in basic research related to stem cell-regenerative medicine, stem cell-immunotherapy and immune cell-tumor therapy, research and development of new cell biotherapy technologies and new drugs, product clinical transformation, and introduction of new technologies in related fields and service consulting.

Kangcell Biotechnology Headquarter Location

Building A18, Dadi Enterprise Park, No.358, BOE Avenue, Beibei District

Chongqing, Chongqing,

China

023-63170660

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Kangcell Biotechnology Investments

1 Investments

Kangcell Biotechnology has made 1 investments. Their latest investment was in Better Biotech as part of their Angel on October 10, 2021.

CBI Logo

Kangcell Biotechnology Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

10/18/2021

Angel

Better Biotech

Yes

2

Date

10/18/2021

Round

Angel

Company

Better Biotech

Amount

New?

Yes

Co-Investors

Sources

2

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.